Stocklytics Platform
Asset logo for symbol CABA
Cabaletta Bio
CABA51
$3.25arrow_drop_down1.36%-$0.04
Penny Stock
Asset logo for symbol CABA
CABA51

$3.25

arrow_drop_down1.36%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Cabaletta Bio (CABA) Stocklytics Forecast

Cabaletta Bio Inc (CABA) is a biopharmaceutical company focused on the discovery and development of T cell therapies for the treatment of B cell-mediated autoimmune diseases. The company's lead product candidate, DSG3-CAART, is being evaluated in clinical trials for the treatment of mucosal pemphigus vulgaris (mPV), a rare autoimmune disease. With its innovative approach to targeting autoreactive B cells, Cabaletta Bio aims to provide patients with a potentially curative therapy option.
When it comes to predicting the future stock price of Cabaletta Bio Inc (CABA), there are several factors to consider. One of the main indicators is the company's financial performance and growth prospects. Analysts and investors often look at factors such as revenue growth, profitability, and pipeline development to assess the company's potential. Additionally, market trends and competitive landscape can also play a role in determining the stock's future performance.
add Cabaletta Bio  to watchlist

Keep an eye on Cabaletta Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Cabaletta Bio (CABA) stock?

Analysts have set a target price of $19.74 for Cabaletta Bio (CABA), based on forecasts from 27 analysts. The predicted price range extends from a high of $50 to a low of $3. This represents a potential increase of up to 1.44K% and a decrease of -7.69% from the current price of $3.25. These forecasts are as of 2022 May 25.
help

What are the analyst ratings for Cabaletta Bio (CABA) stock?

The analyst ratings for Cabaletta Bio (CABA) are distributed as follows: 12 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Cabaletta Bio .
help

What is the AI price prediction for Cabaletta Bio (CABA) stock?

At present, there is no AI or machine-learning-based price prediction available for Cabaletta Bio (CABA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level